The distribution of BPIs for the three clinical subtypes is shown in Figure 3A. There are no significant differences between median BPI among the 3 clinical subtypes of breast cancer, although there is a trend towards higher BPI in the HER2 and TNBC subtypes. This evidence concerns the gene ERBB2 and breast carcinoma.